Danaher Corporation vs iShares MSCI Germany (DAX) — how do they compare? Danaher Corporation trades at $201.25 (market cap $140.88B), while iShares MSCI Germany (DAX) trades at $41.42. The key difference: Danaher Corporation pays a 0.8% dividend while iShares MSCI Germany (DAX) pays none. Which is the better fit depends on your goals.
| DHR | EWG | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $242.05 | $44.56 |
52-Week Low | $161.91 | $38.08 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
EWG is trading at $41.23, down 0.63% on the day amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. Recent German economic developments, including healthcare reforms and ECB rate hikes, create a mixed backdrop for European-focused investments.
The outlook remains cautious with technical indicators favoring sellers, while fundamental data is unavailable. Key risks include European economic volatility and regulatory changes. Investors should monitor German economic indicators and company-specific financial disclosures for clearer direction.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →